Assignee
ONYX THERAPEUTICS INC
US·33 granted patents·20 pending applications·355 citations·filing 2005–2022
Top patents by PatentIndex Score
53 records- 0198US7691852B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2007·Granted Apr 6, 2010·65 cites·4 claims
- 0297US8431571B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2012·Granted Apr 30, 2013·33 cites·46 claims
- 0397US8357683B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2011·Granted Jan 22, 2013·34 cites·22 claims
- 0496US8367617B2Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxidesONYX THERAPEUTICS INC·Filed 2008·Granted Feb 5, 2013·34 cites·8 claims
- 0593US9511109B2Combination therapy with peptide epoxyketonesONYX THERAPEUTICS INC·Filed 2014·Granted Dec 6, 2016·10 cites·5 claims
- 0693US7737112B2Composition for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2005·Granted Jun 15, 2010·87 cites·32 claims
- 0790US9434761B2Tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2014·Granted Sep 6, 2016·13 cites·20 claims
- 0890US8609654B1Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Granted Dec 17, 2013·8 cites·60 claims
- 0989US9205125B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Granted Dec 8, 2015·8 cites·48 claims
- 1089US9205126B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Granted Dec 8, 2015·8 cites·40 claims
- 1189US9205124B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Granted Dec 8, 2015·8 cites·34 claims
- 1288US10159746B2Cyclodextrin complexation methods for formulating peptide proteasome inhibitorsONYX THERAPEUTICS INC·Filed 2013·Granted Dec 25, 2018·14 cites·30 claims
- 1387US9051353B2Crystalline tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2013·Granted Jun 9, 2015·7 cites·14 claims
- 1486US8921583B2Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxidesONYX THERAPEUTICS INC·Filed 2013·Granted Dec 30, 2014·7 cites·16 claims
- 1582US9315542B2Prodrugs of peptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2013·Granted Apr 19, 2016·4 cites·30 claims
- 1679US10647744B2Tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2016·Granted May 12, 2020·2 cites·38 claims
- 1778US2021179663A1Compounds for proteasome enzyme inhibitionONYX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1877US8921324B2Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxidesONYX THERAPEUTICS INC·Filed 2013·Granted Dec 30, 2014·2 cites·15 claims
- 1976US9309283B2Prodrugs of peptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2013·Granted Apr 12, 2016·2 cites·54 claims
- 2076US8765745B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2012·Granted Jul 1, 2014·1 cites·100 claims
- 2174US2020071356A1Compounds for proteasomeONYX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2273US9657057B2Dipeptide and tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2014·Granted May 23, 2017·2 cites·21 claims
- 2372US2019211058A1Compounds for proteasome enzyme inhibitionONYX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2471US10022326B2Liposomal compositions of epoxyketone-based proteasome inhibitorsONYX THERAPEUTICS INC·Filed 2013·Granted Jul 17, 2018·4 cites·26 claims
- 2569US11078233B2Tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2020·Granted Aug 3, 2021·0 cites·27 claims
- 2669US2014342977A1Compounds for proteasome enzyme inhibitionONYX THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2769US2018170962A1Compounds for proteasome enzyme inhibitionONYX THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2868US2020254051A1Combination therapy with peptide epoxyketonesONYX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2967US9295708B2Modified release formulations for oprozomibONYX THERAPEUTICS INC·Filed 2013·Granted Mar 29, 2016·2 cites·6 claims
- 3067US2023235406A1Immunoglobulin expression levels as biomarker for proteasome inhibitor responseONYX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3167US2011236428A1Combination therapy with peptide epoxyketonesONYX THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 3266US10150794B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2017·Granted Dec 11, 2018·0 cites·1 claims
- 3366US2014100169A1Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3466US2014080753A1Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3565US8735441B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2012·Granted May 27, 2014·0 cites·26 claims
- 3664US10682419B2Prodrugs of peptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2018·Granted Jun 16, 2020·0 cites·19 claims
- 3764US2013324459A1Compounds For Enzyme InhibitionONYX THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3864US2016222057A1Compounds for proteasome enzyme inhibitionONYX THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3963USRE47302EPeptide epoxyketone immunoproteasome inhibitorsONYX THERAPEUTICS INC·Filed 2017·Granted Mar 19, 2019·0 cites·31 claims
- 4062USRE47954ECombination therapy with peptide epoxyketonesONYX THERAPEUTICS INC·Filed 2017·Granted Apr 21, 2020·0 cites·17 claims
- 4162US2020289606A1Peptide epoxyketone proteasome inhibitors in combination with pim kinase inhibitors for treatment of cancersONYX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4262US2015361134A1Compounds for proteasome enzyme inhibitionONYX THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4361US10596222B2Combination therapy with peptide epoxyketonesONYX THERAPEUTICS INC·Filed 2016·Granted Mar 24, 2020·0 cites·6 claims
- 4461US9657058B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2015·Granted May 23, 2017·0 cites·15 claims
- 4560US2021238691A1Immunoglobulin expression levels as biomarker for proteasome inhibitor responseONYX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4659US2016083421A1Compunds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4756US9878047B2Prodrugs of peptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2016·Granted Jan 30, 2018·0 cites·13 claims
- 4855US9403868B2Crystalline tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2015·Granted Aug 2, 2016·0 cites·11 claims
- 4952US10870889B2Immunoglobulin expression levels as biomarker for proteasome inhibitor responseONYX THERAPEUTICS INC·Filed 2014·Granted Dec 22, 2020·0 cites·13 claims
- 5052US2014364377A1Use of peptide epoxyketones for metastasis suppressionONYX THERAPEUTICS INC·Filed 2014·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ONYX THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →